Product Images Pregabalin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 14 images provide visual information about the product associated with Pregabalin NDC 50090-5177 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Label Image - lbl500905177
This text contains information about the product "Pregabaltn" that comes in a packaging of 90 capsules and should be stored at 810 7 okGRgES ยข temperature. The remaining text, including numbers and symbols, does not provide any relevant information.*
Figure 1 - pregabalincaps fig01
Figure 2 - pregabalincaps fig02
This text provides information about the percentage improvement in pain from baseline for patients taking Pregabalin 160mg for a 3-day period. The percentages listed are 100, 2, and 10. There are also some numbers listed in a table format, including 220, 23, 20, and 280, but it is unclear what they represent. The word "Facebo" is included, but it is not clear what it refers to.*
Figure 3 - pregabalincaps fig03
This appears to be a chart or data with some numbers and drug names. It is not clear what the chart is referring to and what the numbers represent. Therefore, the description cannot be provided.*
Figure 4 - pregabalincaps fig04
Not-Available. The text contains non-sensical characters and no readable sentence.*
Figure 5 - pregabalincaps fig05
This appears to be a chart comparing the effectiveness of different doses of Fregabalin and Pregataiin (likely misspelled versions of the medications Pregabalin and Pregabalin). It also includes a placebo group. The chart measures the percentage of patients who experienced improvement in pain, as well as the percentage of improvement in pain from baseline. However, there is a lot of missing or unclear information, so the usefulness of this chart is limited.*
Figure 6 - pregabalincaps fig06
Figure 7 - pregabalincaps fig07
Figure 8 - pregabalincaps fig08
The text describes a chart showing the percentage of patients who experienced improvement in pain from baseline after taking either a daily dose of Pregabalin 300mg or Pregabalin 450mg. The chart also includes a comparison with a placebo group. The X-axis shows the range of percent improvement from 20 to 280.*
Figure 9 - pregabalincaps fig09
This appears to be a chart showing the estimated percentages of subjects without LTR (not clear what this stands for) over a period of 120 days. The chart also includes labels for "Progabain" and "Placebo."*
Figure 11 - pregabalincaps fig10
Figure 12 - pregabalincaps fig11
This table shows the percentage of subjects who improved from baseline to week 16 for pregabalin and placebo. The values range from 100 to 280 and are plotted against specific values of 210 to 270.*
Cockcroft and Gault equation - pregabalincaps formula
This is a medical formula to calculate the creatinine clearance rate (CLCT) in patients, which helps to determine the kidney function. The formula requires the patient's age, weight, and serum creatinine levels in milligrams per deciliter (mg/dL). For female patients, the result is multiplied by 0.85.*
Chemical Structure - pregabalincaps str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.